These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30355035)

  • 1. Novel Beneficial Cardiovascular Effects of Natural Activators of Autophagy.
    Frati G; Vecchione C; Sciarretta S
    Circ Res; 2018 Sep; 123(8):947-949. PubMed ID: 30355035
    [No Abstract]   [Full Text] [Related]  

  • 2. Crosstalk between Autophagy and Apoptosis: Potential and Emerging Therapeutic Targets for Cardiac Diseases.
    Li M; Gao P; Zhang J
    Int J Mol Sci; 2016 Mar; 17(3):332. PubMed ID: 26950124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy in Cardiovascular Aging.
    Abdellatif M; Sedej S; Carmona-Gutierrez D; Madeo F; Kroemer G
    Circ Res; 2018 Sep; 123(7):803-824. PubMed ID: 30355077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases.
    Luo W; Gui DD; Yan BJ; Ren Z; Peng LJ; Wei DH; Liu LS; Zhang DW; Jiang ZS
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):113-121. PubMed ID: 32090295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II- and Alzheimer-Type Cardiovascular Aging.
    Cooper HA; Scalia R; Rizzo V; Eguchi S
    Circ Res; 2018 Aug; 123(6):651-653. PubMed ID: 30355238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in cardiovascular health and disease.
    Abdellatif M; Ljubojevic-Holzer S; Madeo F; Sedej S
    Prog Mol Biol Transl Sci; 2020; 172():87-106. PubMed ID: 32620252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy as a regulator of cardiovascular redox homeostasis.
    Yan Y; Finkel T
    Free Radic Biol Med; 2017 Aug; 109():108-113. PubMed ID: 27940349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular autophagy: crossroads of pathology, pharmacology and toxicology.
    Salabei JK; Conklin DJ
    Cardiovasc Toxicol; 2013 Sep; 13(3):220-9. PubMed ID: 23408289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organs-on-chip models for cardiovascular drug development.
    Zimmermann WH
    Cardiovasc Res; 2021 Nov; 117(12):e164-e165. PubMed ID: 34347045
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic potential of neuregulin-1 in cardiovascular disease.
    Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.
    Jiang W; Liu M; Gu C; Ma H
    Cardiovasc Toxicol; 2021 Jan; 21(1):2-11. PubMed ID: 33006052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of sphingosine-1-phosphate (S1P).
    Levkau B
    Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of autophagy by some natural products as a potential therapeutic strategy for cardiovascular disorders.
    Hashemzaei M; Entezari Heravi R; Rezaee R; Roohbakhsh A; Karimi G
    Eur J Pharmacol; 2017 May; 802():44-51. PubMed ID: 28238768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin' the Heart: A Novel Therapeutic Modality.
    Raleigh JM; Toldo S; Das A; Abbate A; Salloum FN
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):353-62. PubMed ID: 26589290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature.
    Herring MJ; Oskui PM; Hale SL; Kloner RA
    J Am Heart Assoc; 2013 Jul; 2(4):e000271. PubMed ID: 23842280
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: From the Editor-in-Chief.
    Kang YJ
    Cardiovasc Toxicol; 2021 Jan; 21(1):1. PubMed ID: 33387251
    [No Abstract]   [Full Text] [Related]  

  • 17. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target.
    Zhou H; Li N; Yuan Y; Jin YG; Guo H; Deng W; Tang QZ
    Basic Res Cardiol; 2018 Aug; 113(5):37. PubMed ID: 30094473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin and cardiovascular diseases: Focus on cellular targets and cascades.
    Pourbagher-Shahri AM; Farkhondeh T; Ashrafizadeh M; Talebi M; Samargahndian S
    Biomed Pharmacother; 2021 Apr; 136():111214. PubMed ID: 33450488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide signalling in cardiovascular health and disease.
    Farah C; Michel LYM; Balligand JL
    Nat Rev Cardiol; 2018 May; 15(5):292-316. PubMed ID: 29388567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.